Pular para o conteúdo
Merck
Todas as fotos(3)

Documentos

M9692

Sigma-Aldrich

Anti-MAP Kinase, Activated (Diphosphorylated ERK-1&2) antibody, Mouse monoclonal

clone MAPK-YT, purified from hybridoma cell culture

Sinônimo(s):

Monoclonal Anti-MAP Kinase, Activated (Diphosphorylated ERK-1&2)

Faça loginpara ver os preços organizacionais e de contrato


About This Item

Código UNSPSC:
12352203
NACRES:
NA.44

fonte biológica

mouse

Nível de qualidade

conjugado

unconjugated

forma do anticorpo

purified immunoglobulin

tipo de produto de anticorpo

primary antibodies

clone

MAPK-YT, monoclonal

forma

buffered aqueous solution

peso molecular

antigen ERK-1 44 kDa
antigen ERK-2 42 kDa

reatividade de espécies

human, Caenorhabditis elegans, Xenopus, Drosophila, hamster, rat, bovine, mouse, yeast

embalagem

antibody small pack of 25 μL

concentração

1.5-2 mg/mL

técnica(s)

immunocytochemistry: suitable
immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable
immunoprecipitation (IP): suitable
indirect ELISA: suitable
microarray: suitable
western blot: 0.5-1 μg/mL using a whole cell extract of RAT-1 cells treated with vanadate and H2O2.

Isotipo

IgG1

nº de adesão UniProt

Condições de expedição

dry ice

temperatura de armazenamento

−20°C

modificação pós-traducional do alvo

unmodified

Informações sobre genes

Procurando produtos similares? Visita Guia de comparação de produtos

Descrição geral

Mitogen-activated protein kinase (MAPK) are also known as the extracellular signal-regulated kinase (ERKs), they exist in two isoforms namely, ERK1 (MAPK3) and ERK2 (MAPK1). ERK2 is mapped to human chromosome 22q11.2. ERK1 is located on human chromosome 16p11.2.
Anti-MAP Kinase, Activated (Diphosphorylated ERK-1&2) antibody, Mouse monoclonal (mouse IgG1 isotype) is derived from the MAPK-YT hybridoma produced by the fusion of mouse myeloma cells (NS1) and splenocytes from BALB/c mice immunized with a synthetic phosphorylated peptide containing amino acids corresponding to the phosphorylated form of ERK-activation loop, conjugated to KLH. The isotype is determined by a double diffusion immunoassay using Mouse Monoclonal Antibody Isotyping Reagents, Product Number ISO2.

Especificidade

Monoclonal Anti-MAP Kinase, Activated (Diphosphorylated ERK-1&2) is specific for the active, dually-phosphorylated form of MAP kinase (ERK-1 and ERK-2, 44 kDa and 42 kDa, respectively). Reactivity has been observed with human, bovine, rat, mouse, hamster, Xenopus, Drosophila, Spodoptera frugiperda, C. elegans, and yeast.
The antibody reacts specifically with the diphosphorylated form of MAP kinase (ERK-1 and ERK-2). It does not recognize the non-phosphorylated or the monophosphorylated forms of MAP kinase or the diphosphorylated forms of JNK and p38 MAP kinase. The epitope recognized by the antibody contains the phosphorylated threonine and tyrosine residues within the regulatory site of active MAP kinase.

Imunogênio

synthetic peptide HTGFLpTEpYVAT corresponding to the phosphorylated form of the ERK-activation loop.

Aplicação

The antibody may be used for immunoblotting applications at a working concentration of 0.5-1.0 μg/mL in cultured cells as well as tissue extracts. A working dilution of 1:80-1:100 is suitable for immunohistochemistry (formalin and formaldehyde-fixed sections). The antibody may also be used for immunocytochemistry, immunoprecipitation, indirect ELISA and protein microarray.
Monoclonal Anti-MAP Kinase, activated (Diphosphorylated ERK-1&2) antibody produced in mouse has been used in detection of
  • ERK1/2 in cardiac myocytes using immunofluorescence microscopy
  • ERK1/2 in human eosinophils using western blotting
  • ERK in human bronchial epithelial cells using protein array
  • ERK proteins in human liver cell lines using immunofluorescence assay and western blot analysis
  • ERK1/2 in human embryonic kidney cells by immunoprecipitation

Ações bioquímicas/fisiológicas

Mitogen-activated protein kinase (MAPK) superfamily of enzymes is involved in widespread signalling pathways. Members of this family include the ERK1/2 (extracellular signal-regulated protein kinase, also termed p42/p44 MAPK), JNK and p38 MAPK subfamilies. These are the terminal enzymes in a signalling cascade where each kinase phosphorylates and activates the next member in the sequence. Phosphorylation of both tyrosine and threonine is essential for the full activation of all MAPKs. Several kinases participate in activation of the ERK cascade. This cascade is initiated by the small G protein Ras, which upon stimulation causes activation Raf1 kinase. Raf1 continues the transmission by activating MEK. Activated MEK appears to be the only kinase capable of specifically phosphorylating and activating ERK. ERK appears to be an important regulatory molecule, which by can phosphorylate regulatory targets in the cytosol (phospholipase A2, PLA2), translocated into and phosphorylate substrates in the nucleus (ELK1). The activation of ERK cascade mediates and regulates the signal transduction pathways in response to stress, mitogenic signals and is important in development and differentiation, learning, memory and survival.
Monoclonal Anti-MAP Kinase, Activated (Diphosphorylated ERK-1 and 2) is specific for the active, dually-phosphorylated form of MAP kinase (ERK-1 and ERK-2, 44 kDa and 42 kDa, respectively). The epitope recognized by the antibody contains the phosphorylated threonine and tyrosine residues within the regulatory site of active MAP kinase (Thr183 and Tyr185 in ERK-2). It does not recognize the non-phosphorylated or the monophosphorylated forms of the MAP kinase molecule or the diphosphorylated form of Jun-kinase (JNK) and p38 MAP kinase.
Signaling pathways mediated by MAPK are associated in the pathogenesis of neurodegenerative disorders and cancer. Deletion in the ERK1 gene locus is associated with DiGeorge syndrome (DGS) and velocardiofacial syndrome (VCFS) and congenital heart defects. Rearrangements in MAPK3 gene locus may contribute in the pathogenesis of autism spectrum disorders and schizophrenia.

forma física

Solution in phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

Armazenamento e estabilidade

For continuous use, store at 2-8 °C for up to one month. For extended storage, freeze in working aliquots at -20 °C. Repeated freezing and thawing, or storage in frost free freezers, is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilutions should be discarded if not used within 12 hours.

Exoneração de responsabilidade

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Ferramenta de seleção de produtos.

Código de classe de armazenamento

12 - Non Combustible Liquids

Classe de risco de água (WGK)

nwg

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable

Equipamento de proteção individual

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)


Certificados de análise (COA)

Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Long non-coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway.
Bao H, et al.
Oncology Letters, 14(3), 2831-2837 (2017)
Pathological roles of MAPK signaling pathways in human diseases.
Kim EK and Choi EJ
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1802(4), 396-405 (2010)
Congenital heart defects in a novel recurrent 22q11. 2 deletion harboring the genes CRKL and MAPK1.
Breckpot J, et al.
American Journal of Medical Genetics, 158(3), 574-580 (2012)
Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD.
Milara J, et al.
Pulmonary Pharmacology & Therapeutics, 28(2), 138-148 (2014)
Detection of partially phosphorylated forms of ERK by monoclonal antibodies reveals spatial regulation of ERK activity by phosphatases
Yao Z et al
Febs Letters, 468, 34-42 (2000)

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica